Bicyclic heterocyclic p-38 kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/437 (2006.01) A61P 29/00 (2006.01) C07D 473/00 (2006.01)

Patent

CA 2548326

Provided are bicyclic heterocycle-based p38 kinase, including p38.alpha. and p38.beta. kinase, inhibitors. Pharmaceutical compositions containing the compounds are also provided. Methods of use of the compounds and compositions are also provided, including methods of treatment, prevention, or amehoration of one or more symptoms of p38 kinase mediated diseases and disorders, including, but not limited to, inflammatory diseases and disorders.

La présente invention se rapporte à des inhibiteurs hétérocycliques bicycliques des kinases p38, notamment des kinases p38.alpha. et p38.beta.. L'invention concerne aussi des compositions pharmaceutiques contenant lesdits composés. L'invention a également trait à des procédés d'utilisation des composés et des compositions selon l'invention, notamment à des méthodes permettant de traiter, de prévenir ou d'atténuer un ou plusieurs symptômes de maladies et troubles induits par les kinases p38, notamment, mais de façon non limitative, des maladies et des troubles inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic heterocyclic p-38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic heterocyclic p-38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocyclic p-38 kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1604086

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.